Neumora Therapeutics, Inc.
NMRANext catalyst
No upcoming catalyst in our data
No upcoming FDA decision, filing or trial readout is on file for NMRA. That does not mean none is planned.
Get an email about NMRA's next catalysts
Track Neumora Therapeutics (NMRA) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
1 upcoming event in our data (earnings).See the timeline
2 upcoming, 0 past
NMRA Reports Financial Results
Filed: 2026-11-16 AccNo: 0001193125-26-462165 Size: 355 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits
SourceNMRA Earnings Report
Date estimated from past reporting pattern, not yet confirmed by the company | EPS Est: $-0.19 | FQ end Sep/2026 | Call: tbd
How NMRA's past catalysts played out
Market Overview
Stock performance and key metrics
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
NMRA-335140 | Phase 3 | Major Depressive Disorder | - | - |
Frequently asked questions
What is in Neumora Therapeutics, Inc.'s drug pipeline?β
CatalystAlert tracks 1 drug candidate in Neumora Therapeutics, Inc.'s (NMRA) pipeline across Phase 3. Its lead program is NMRA-335140 (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Neumora Therapeutics, Inc.'s next FDA catalyst?β
CatalystAlert tracks every upcoming catalyst for Neumora Therapeutics, Inc. (NMRA) β PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings β each confidence-rated as confirmed, estimated or AI-detected.
How do I track NMRA biotech catalysts?β
Add NMRA to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Neumora Therapeutics, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page β sourced from ClinicalTrials.gov, FDA and SEC filings.
